Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Goodman

Showing results (351-360 of 409) with videos related to

Pageof 41
Sort By:
BMJ Open|December 30, 2017
Cohort profile: Study of Transition, Outcomes and Gender (STRONG) to assess health status of transgender peopleVirginia P Quinn, Rebecca Nash, Enid Hunkeler, et al.
European Urology|March 5, 2018
Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study ResultsMark Douglas Tyson, Tatsuki Koyama, Dan Lee, et al.
Cancer|February 11, 2014
Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatmentMatthew J Resnick, Daniel A Barocas, Alicia K Morgans, et al.
Acta Oncologica (Stockholm, Sweden)|November 1, 2019
17β-Hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence: a Danish population-based studyLindsay J Collin, Sinna P Ulrichsen, Thomas P Ahern, et al.
Cancer|May 3, 2017
Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data BaseKushal B Naik, Yuan Liu, Michael Goodman, et al.
JAMA|March 22, 2017
Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 YearsDaniel A Barocas, JoAnn Alvarez, Matthew J Resnick, et al.
Archives of Internal Medicine|April 23, 2002
Gastric and duodenal safety of daily alendronateJames G Donahue, K Arnold Chan, Susan E Andrade, et al.
European Urology|February 27, 2020
Development and Internal Validation of a Web-based Tool to Predict Sexual, Urinary, and Bowel Function Longitudinally After Radiation Therapy, Surgery, or ObservationAaron A Laviana, Zhiguo Zhao, Li-Ching Huang, et al.
Breast Cancer Research : BCR|December 30, 2025
17β-Hydroxysteroid dehydrogenases 1 and 2: potential markers for breast cancer recurrence and tamoxifen resistance among premenopausal women diagnosed with breast cancer in DenmarkLindsay J Collin, Kirsten M Woolpert, Anders Kjaersgaard, et al.
Transfusion|December 22, 2024
Patterns of platelet use evaluated in EHR networks of the Biologics Effectiveness and Safety Initiative, 2012-2018Carlos H Villa, Paul Biondich, Nicole L Draper, et al.
Pageof 41

Showing results (351-360 of 409) with videos related to

Sort By:
Pageof 41
BMJ Open|December 30, 2017
Cohort profile: Study of Transition, Outcomes and Gender (STRONG) to assess health status of transgender peopleVirginia P Quinn, Rebecca Nash, Enid Hunkeler, et al.
European Urology|March 5, 2018
Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study ResultsMark Douglas Tyson, Tatsuki Koyama, Dan Lee, et al.
Cancer|February 11, 2014
Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatmentMatthew J Resnick, Daniel A Barocas, Alicia K Morgans, et al.
Acta Oncologica (Stockholm, Sweden)|November 1, 2019
17β-Hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence: a Danish population-based studyLindsay J Collin, Sinna P Ulrichsen, Thomas P Ahern, et al.
Cancer|May 3, 2017
Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data BaseKushal B Naik, Yuan Liu, Michael Goodman, et al.
JAMA|March 22, 2017
Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 YearsDaniel A Barocas, JoAnn Alvarez, Matthew J Resnick, et al.
Archives of Internal Medicine|April 23, 2002
Gastric and duodenal safety of daily alendronateJames G Donahue, K Arnold Chan, Susan E Andrade, et al.
European Urology|February 27, 2020
Development and Internal Validation of a Web-based Tool to Predict Sexual, Urinary, and Bowel Function Longitudinally After Radiation Therapy, Surgery, or ObservationAaron A Laviana, Zhiguo Zhao, Li-Ching Huang, et al.
Breast Cancer Research : BCR|December 30, 2025
17β-Hydroxysteroid dehydrogenases 1 and 2: potential markers for breast cancer recurrence and tamoxifen resistance among premenopausal women diagnosed with breast cancer in DenmarkLindsay J Collin, Kirsten M Woolpert, Anders Kjaersgaard, et al.
Transfusion|December 22, 2024
Patterns of platelet use evaluated in EHR networks of the Biologics Effectiveness and Safety Initiative, 2012-2018Carlos H Villa, Paul Biondich, Nicole L Draper, et al.
Pageof 41